Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: C31G vaginal gel; Glyminox gel; PRE 106; SAVVY

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Biosyn
  • Developer Biosyn; Louisiana State University Health Sciences Center; National Institute of Child Health and Human Development
  • Class Amines; Antibacterials; Antivirals; Small molecules; Spermicidal contraceptives; Unsaturated fatty acids
  • Mechanism of Action Membrane lipid inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Pregnancy

Highest Development Phases

  • Suspended Pregnancy
  • No development reported Dendritic keratitis
  • Discontinued Chlamydial infections; Gonorrhoea; HIV infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Dendritic-keratitis in USA (Ophthalmic)
  • 09 Sep 2013 Preclinical trials in Dendritic keratitis in USA (Ophthalmic)
  • 09 Sep 2013 Pharmacodynamics and adverse events data from preclinical studies in Dendritic keratitis released by Adamis Pharmaceuticals Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top